Revolution Medicines, Inc. (RVMD) Return on equity 2020–2025
Revolution Medicines, Inc. (RVMD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-69.3%FY2025 · since FY2020: -22.8% → -69.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -69.3% | -42.8 pp |
| FY2024 | -26.5% | -2.6 pp |
| FY2023 | -23.9% | +12.5 pp |
| FY2022 | -36.3% | -5.3 pp |
| FY2021 | -31.0% | -8.2 pp |
| FY2020 | -22.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice